Ribavirin in hepatitis C related cryoglobulinemia

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1115-1117

  Durand, Jean Marc ^a,d   Cacoub, Patrice ^b   Lunel Fabiani, Françoise ^b   Cosserat, Julie ^c   Cretel, Elodie ^a   Kaplanski, Gilles ^a   Frances, Camille ^b   Bletry, Olivier ^c   Soubeyrand, Jacques ^a   Godeau, Pierre ^b  

^a CHU Sainte Marguerite

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Department of Internal Medicine   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Cryoglobulinemia; Hepatitis C virus; Virazole

Indexed keywords

AMINOTRANSFERASE; GUANOSINE DERIVATIVE; INTERFERON; RIBAVIRIN;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOGLOBULINEMIA; DOSE RESPONSE; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PURPURA; SENSORY NEUROPATHY; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULITIS; WEIGHT REDUCTION;

AGED; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TRANSAMINASES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0031855840     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327: 1490-5.
2. Cacoub P, Lunel-Fabiani F, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
3. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-300.
4. Ferri C, Marzo E, Longombardo G, et al. Interferon-alpha in mixed cryoglobulinemia patients: randomized, crossover controlled trial. Blood 1993;81:1132-6.
5. Misiani R, Bellavita P, Fenili D, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;33:751-6.
6. Durand JM, Kaplanski G, Lefevre P, et al. Effect of interferon alpha on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis 1992;165:778-9.
7. Shindo M, Di Bisceglie AM, Cheung L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700-6.
8. Kolberg L, Sanchez-Pescador R, Detmer J, et al. Branched DNA (b DNA) quantitation of hepatitis C viral RNA in patient sera. In: Groupe français d'études moléculaires des hépatites, editors. Hepatitis C virus: new diagnostic tool. Paris: John Libbey Eurotext, 1994:57-69.
9. Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B hepatitis. A meta-analysis of randomized clinical trials. J Hepatol 1991;13:192-9.
10. Reichard O, Andersson J, Schvarcz R, Weiland O. Ribavirin treatment for chronic hepatitits C. Lancet 1991;337:1058-61.
11. Di Bisceglie AM, Shindo M, Fong TL, et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992;16: 649-54.
12. Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993;19:408-12.
13. Reichard O, Yun ZB, Sonnerborg A, Weiland O. Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. J Med Virology 1993;41:99-102.
14. Tong MJ, Hwang SJ, Lefkowitz M, et al. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J Gastroenterol Hepatol 1994;9:587-91.
15. Gane EJ, Tibbs CJ, Ramage J, Portmann B, Williams R. Ribavirin therapy for hepatitis C infection following liver transplantation. Transplant Int 1995;8:61-4.
16. Di Bisceglie AM, Conjeevaram HS, Fried MW, et al. Ribavirin as therapy for chronic hepatitis C. Ann Intern Med 1995;123:897-903.
17. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 1993;105:507-12.
18. Brillanti S, Garson J, Foli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994;107:812-7.
19. Koskinas J, Tibbs C, Saleh MG, Pereira LM, McFarlane IG, Williams R. Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virology 1995;45:29-34.
20. Schvarcz R, Yun ZB, Sonnerborg A, Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virology 1995;46:43-7.
21. Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 1996;111:1307-12.
22. Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral induced macrophage production of TNF, IL-1 and procoagulant activity and preserves Th1 cytokine production, but inhibits Th2 cytokine response. Hepatology 1996;24:355.